TrialAnnals of internal medicine2022

Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based Study.

Ghadeer K Dawwas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.